← Open Payments lookup

ZORYANA TUZ: Open Payments

NPI 1982055158 · NEPTUNE CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,448 in 31 payments from 13 companies in 2025. Trend: 2023 $852 · 2024 $1,413 · 2025 $1,448

Food & beverage: $1,448
CompanyPaymentsAmount
Amgen Inc.4$282
Alnylam Pharmaceuticals Inc.3$271
Novo Nordisk Inc6$259
E.R. Squibb & Sons, L.L.C.7$214
AstraZeneca Pharmaceuticals LP1$124
Actelion Pharmaceuticals US, Inc.1$87
Boston Scientific Corporation2$60
ABIOMED1$38
Boehringer Ingelheim Pharmaceuticals, Inc.2$37
Lilly USA, LLC1$20

Products named: Repatha, AMVUTTRA, Wegovy, CAMZYOS, WAINUA, Ozempic, UPTRAVI, ELIQUIS.

Industry payments across NJ — which companies pay providers there.